Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Empyrean Medical Systems has launched the Morpheus™ image-guided radiotherapy system after rapid FDA clearance. The company holds exclusive rights to develop and commercialize the MOVHEET technology from MD Anderson. Its pipeline includes advanced medical devices for radiation therapy, novel therapeutic compounds under partnership with UCSD, and AI-driven software platforms. No published clinical trial results yet; products are at various stages from commercial launch to early-stage R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Empyrean Medical Systems.